Skip to main content

Diabetes

  • New game app improves adherence among diabetes patients, study finds

    SANTA CLARA, Calif. — A new mobile game app designed by CyberDoctor showed improvements in medication adherence, diet and exercise in diabetes patients, according to a study.

    The company said that breakthrough clinical trial results for the game, called PatientPartner," documented for the first time the effectiveness of a story-driven game in changing health behavior and biomarkers. The study was conducted among 100 nonadherence patients at Hershey, Pa.-based Pinnacle Health Systems and presented at the Health2.0 Conference Wednesday in Santa Clara, Calif.

  • Research Now launches diabetes panel

    PLANO, Texas — Research Now announced the launch of its Diabetes Panel, a collection of 336,000 deeply-profiled panelists in the United States and Canada who have been diagnosed with Type 1 diabetes, Type 2 diabetes, high blood pressure or obesity. Research Now's Healthcare Panels also include physicians, nurses, pharmacists, hospital executives and administrators.

  • Abbott launches Glucerna Advance RTD to provide nutritional benefits for those with diabetes

    ABBOTT PARK, Ill. — Abbott on Tuesday introduced a new nutrition shake called Glucerna Advance — formulated for people with diabetes who are seeking additional nutrition and health benefits. The new product helps to minimize blood sugar spikes while supporting heart hearth and the immune system, Abbott noted. 

  • U.S. Type 2 diabetes market to more than double by 2019

    NEW YORK — The global market for Type 2 diabetes will nearly double over the next six years, according to a new report.

    GBI Research announced the release of a study Tuesday indicating that the market will grow from 2012's $20.4 billion to $38.8 billion by 2019, at an annual growth rate of 10.2%. The United States' market, meanwhile, will more than double, from $12.7 billion last year to $27.2 billion in 2019.

  • Homeostasis Labs' Diabetic Direct named 'Best New Product' at recent ECRM

    GREENWICH, Conn. — Homeostasis Labs was named "Best New Product" by retail buyers attending the ECRM Home Health Care conference last month for a new sugar-free line of dietary supplements formulated to boost health for people with diabetes. 

  • Bartell Drugs to appear at Seattle diabetes expo

    SEATTLE — Bartell Drugs will play a prominent role at a diabetes expo in Seattle this weekend, the retail pharmacy chain said Wednesday.

  • Hannaford to donate bottle, can deposits to charity

    ALBANY, N.Y. — Customers who recycle bottles and cans with deposit values at Greenback Redemption Centers in Hannaford supermarkets in New York state will have the option of donating the money to local charities.

  • Novo Nordisk launches Race with Insulin contest with Charlie Kimball as spokesman

    BIRMINGHAM, Ala. — Novo Nordisk has launched a diabetes awareness sweepstakes in which the winners get a free trip to the 2013 IndyCar finale, the Danish drug maker said Friday.

    The company announced that it had hired IZOD IndyCar Series Charlie Kimball as spokesman for its Race with Insulin contest. Kimball, the first licensed driver with diabetes to race at the highest level of the series, was diagnosed with the disease during a routine doctor visit in 2007 while racing in Europe and is a user of Novo Nordisk's NovoLog (insulin aspart [rDNA origin]).

X
This ad will auto-close in 10 seconds